Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study

OBJECTIVE: To determine treatment persistence and exacerbations in patients initiating inhaler treatment with fixed-dose combinations of inhaled corticosteroids/long-acting beta-2-adrenergic agonists (ICS/LABA) for the treatment of asthma. DESIGN: Retrospective observational study conducted by revie...

Full description

Bibliographic Details
Main Authors: Fernández-Sánchez, T. (Author), Gómez Rodríguez, B. (Author), Sicras-Mainar, A. (Author), Traseira-Lugilde, S. (Author), Velasco Garrido, J.L (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Administration, Inhalation
adolescent
Adolescent
Adrenal Cortex Hormones
Adrenergic beta-Agonists
adult
Adult
antiasthmatic agent
Anti-Asthmatic Agents
asthma
Asthma
beta adrenergic receptor stimulating agent
budesonide plus formoterol
Budesonide, Formoterol Fumarate Drug Combination
corticosteroid
drug combination
Drug Combinations
female
Female
fluticasone
Fluticasone
formoterol fumarate
Formoterol Fumarate
human
Humans
inhalational drug administration
male
Male
middle aged
Middle Aged
respiratory medicine (see thoracic medicine)
Retrospective Studies
retrospective study
therapeutics
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items